Obesity Trial, Recruiting (NCT04471506)

Obesity Trial, Recruiting NCT04471506 Sponsor: Cairo University Condition: Obesity

Printed from Voxsanity (voxsanity.com.au) — NCT04471506 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Obesity

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women who are postmenopausal and between 55 and 65 years old
Women with a Body Mass Index (BMI) — a measure of body weight relative to height — between 35 and 39.9
Women who have been postmenopausal for more than 2 years

Who may not be able to join:

Women who are currently taking part in a weight-loss program or treatment
Women who are currently taking cholesterol-lowering medications
Women who regularly take certain medications, such as beta-blockers, alpha-blockers, digoxin, diuretics, aspirin, nitrates, or any hormone therapies
Women who have an active long-term illness such as rheumatoid arthritis, an overactive thyroid, or inflammatory bowel disease, or who have diabetes or other unstable hormone-related conditions
Women who have difficulty with memory or thinking that could make it hard to take part in the study
Women who have been diagnosed with cancer or another malignant disease
Women who have donated blood within the last 30 days
Women who have taken part in any other study or research trial within the last 90 days
Women who currently smoke

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: marwa m elsayed, phd, lecturer at physical therapy faculty cairo university

Phone: 01156033818

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04471506

Sponsor: Cairo University

Phase: Not Applicable

Status: Recruiting

Condition: Obesity

Trial contact: 01156033818

More information: https://clinicaltrials.gov/study/NCT04471506

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women who are postmenopausal and between 55 and 65 years old
Women with a Body Mass Index (BMI) — a measure of body weight relative to height — between 35 and 39.9
Women who have been postmenopausal for more than 2 years

Who may not be able to join:

Women who are currently taking part in a weight-loss program or treatment
Women who are currently taking cholesterol-lowering medications
Women who regularly take certain medications, such as beta-blockers, alpha-blockers, digoxin, diuretics, aspirin, nitrates, or any hormone therapies
Women who have an active long-term illness such as rheumatoid arthritis, an overactive thyroid, or inflammatory bowel disease, or who have diabetes or other unstable hormone-related conditions
Women who have difficulty with memory or thinking that could make it hard to take part in the study
Women who have been diagnosed with cancer or another malignant disease
Women who have donated blood within the last 30 days
Women who have taken part in any other study or research trial within the last 90 days
Women who currently smoke

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Cairo University

Registry

ClinicalTrials.gov

Start date

1 August 2020

Est. completion

1 December 2024

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

insulin resistance; sex hormones; blood lipids; tumor markers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov